Characteristics and long‐term prognosis of patients with heart failure and mid‐range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta‐analysis

This study aimed to assess by a meta‐analysis the clinical characteristics, all‐cause and cardiovascular mortality, and hospitalization of patients with heart failure (HF) with mid‐range ejection fraction (HFmrEF) compared with HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).

[1]  A. Mebazaa,et al.  Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long‐Term Registry , 2018, European journal of heart failure.

[2]  Roberto Ferrari,et al.  Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.

[3]  L. Lund,et al.  Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid‐range, and reduced ejection fraction , 2017, European journal of heart failure.

[4]  M. Pfisterer,et al.  Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) , 2017, European journal of heart failure.

[5]  T. Shiroto,et al.  Characterization of heart failure patients with mid‐range left ventricular ejection fraction—a report from the CHART‐2 Study , 2017, European journal of heart failure.

[6]  Gianluigi Savarese,et al.  A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction , 2017, European journal of heart failure.

[7]  A. Shah,et al.  Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis , 2017, Heart.

[8]  A. Bardají,et al.  Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure. , 2017, International journal of cardiology.

[9]  G. Keren,et al.  Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST-Segment Elevation Myocardial Infarction. , 2017, The American journal of cardiology.

[10]  D. Reidpath,et al.  Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients. , 2017, International journal of cardiology.

[11]  L. Lund,et al.  Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study , 2017, Circulation. Heart failure.

[12]  F. Fernández‐Avilés,et al.  Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure. , 2017, Revista espanola de cardiologia.

[13]  F. Fernández-Avilés,et al.  La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca , 2017 .

[14]  D. Carrié,et al.  Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines? , 2017, ESC heart failure.

[15]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[16]  Akshay S. Desai,et al.  Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial , 2016, Circulation. Heart failure.

[17]  A. Shah,et al.  Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. , 2016, Circulation. Heart failure.

[18]  J. Gore,et al.  Magnitude of and Prognostic Factors Associated With 1‐Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings , 2015, Journal of the American Heart Association.

[19]  Deepak L. Bhatt,et al.  Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. , 2014, American heart journal.

[20]  L. Tavazzi,et al.  Co‐morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey , 2014, European journal of heart failure.

[21]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[22]  V. Roger,et al.  Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction , 2012, Circulation. Heart failure.

[23]  Akshay S. Desai,et al.  Heart failure with recovered ejection fraction: a distinct clinical entity. , 2011, Journal of cardiac failure.

[24]  M. Davies,et al.  Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). , 2007, European heart journal.

[25]  Karl Swedberg,et al.  Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients , 2005, Circulation.

[26]  L. Fisher,et al.  Surrogate end points in heart failure. , 2002, Journal of the American College of Cardiology.

[27]  James A. White,et al.  Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis. , 2017, JACC. Heart failure.

[28]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.